CRL
Charles River LaboratoriesStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.02% · Russell 3000 0.02% · Russell 1000 0.02% · US Stock Market 0.02%$278.06-1.28%
as of market close, Sep 18, 2026
☾ AH — —
CRL financial statements
The full income statement, balance sheet, and cash-flow statement for Charles River Laboratories (CRL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 51.6M2024-09 51.1M2024-12 51.1M2025-03 49.1M2025-06 49.2M2025-09 49.2M2025-12 49.2M2026-03 48.2M2026-06 47.7M-7.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 27 ’25 | as ofDec 28 ’24 | as ofDec 30 ’23 | as ofDec 31 ’22 | as ofDec 25 ’21 | |
| Revenue | 4.02B-0.9% | 4.05B-1.9% | 4.13B+3.9% | 3.98B+12.3% | 3.54B+21.1% | |
| Selling, general & administrative | 743M-1.1% | 751M+0.4% | 748M+12.4% | 665M+7.3% | 620M+17.2% | |
| Restructuring | 99.8M-6.7% | 107M+260.4% | 29.7M+261.4% | 8.21M+19.8% | 6.86M-45.6% | |
| Amortization of intangibles | 179M+29.3% | 138M+0.8% | 137M-6.2% | 147M+17.4% | 125M+11.6% | |
| Provision for credit losses | 6.06M-59.0% | 14.8M-18.9% | 18.2M+171.8% | 6.71M+304.7% | 1.66M-74.0% | |
| Operating income | 25.2M-88.9% | 227M-63.2% | 617M-5.2% | 651M+10.4% | 590M+36.3% | |
| Interest expense | 107M-15.3% | 126M-7.6% | 137M+130.6% | 59.3M-19.8% | 73.9M-14.5% | |
| Interest & investment income | 4.94M-42.4% | 8.57M+65.0% | 5.20M+566.2% | 780K+19.6% | 652K-21.8% | |
| Other non-operating income | -22.6M-36.7% | -16.5M-117.3% | 95.5M+213.0% | 30.5M+185.0% | -35.9M-135.9% | |
| Pre-tax income | -99.5M-206.9% | 93.1M-84.0% | 581M-6.7% | 623M+29.6% | 481M+7.5% | |
| Income tax | 42.7M-37.1% | 67.8M-32.8% | 101M-22.6% | 130M+59.2% | 81.9M+0.1% | |
| -144M-750.1% | 22.2M-95.3% | 475M-2.4% | 486M+24.4% | 391M+7.3% | ||
| Net income to non-controlling interest | 2.17M-29.6% | 3.09M-46.3% | 5.75M-10.0% | 6.38M-18.8% | 7.86M+683.9% | |
| Net income to common | -144M-1501.7% | 10.3M-97.8% | 475M-2.4% | 486M | — | |
| -$2.91-1555.0% | $0.20-97.8% | $9.22-2.7% | $9.48+24.7% | $7.60+5.6% | ||
| EPS (basic) | -$2.91-1555.0% | $0.20-97.8% | $9.27-3.1% | $9.57+23.2% | $7.77+5.7% | |
| Weighted-avg shares (basic) | 49.6M-3.5% | 51.4M+0.3% | 51.2M+0.8% | 50.8M+1.0% | 50.3M+1.5% | |
| Weighted-avg shares (diluted) | 49.6M-4.0% | 51.6M+0.3% | 51.5M+0.3% | 51.3M-0.2% | 51.4M+1.6% | |
| Balance Sheet | as ofDec 27 ’25 | as ofDec 28 ’24 | as ofDec 30 ’23 | as ofDec 31 ’22 | as ofDec 25 ’21 | |
| 1.45B+3.1% | 1.40B-12.8% | 1.61B+11.8% | 1.44B+12.9% | 1.27B+6.1% | ||
| Cash & equivalents | 214M+9.8% | 195M-29.7% | 277M+18.3% | 234M-3.0% | 241M+5.6% | |
| Short-term investments | — | — | — | — | 1.06M+3.8% | |
| Accounts receivable | 709M-1.7% | 721M-7.6% | 780M+3.7% | 752M+17.0% | 643M+4.1% | |
| Inventory | 299M+7.4% | 279M-26.7% | 380M+48.6% | 256M+28.5% | 199M+7.2% | |
| Prepaid expenses | 129M+22.1% | 106M+26.9% | 83.4M-22.5% | 108M+10.6% | 97.3M+34.1% | |
| 7.14B-5.2% | 7.53B-8.1% | 8.20B+7.8% | 7.60B+8.2% | 7.02B+27.9% | ||
| Property, plant & equipment | 1.66B+3.2% | 1.60B-2.2% | 1.64B+11.9% | 1.47B+13.5% | 1.29B+14.8% | |
| Operating lease right-of-use | 361M-12.4% | 412M+4.7% | 394M+0.6% | 392M+33.7% | 293M+64.4% | |
| Goodwill | 2.76B-2.9% | 2.85B-8.0% | 3.10B+8.6% | 2.85B+5.1% | 2.71B+49.9% | |
| Intangible assets | 340M-53.0% | 723M-16.3% | 864M-9.5% | 955M-10.0% | 1.06B+34.7% | |
| Deferred tax assets | 67.3M+59.6% | 42.2M+4.7% | 40.3M-2.4% | 41.3M+2.6% | 40.2M+6.6% | |
| Other non-current assets | 293M+5.4% | 278M-10.1% | 309M+108.6% | 148M-2.1% | 152M-57.0% | |
| 1.12B+12.7% | 994M-5.8% | 1.06B-3.3% | 1.09B+5.7% | 1.03B+23.0% | ||
| Accounts payable | 149M+6.0% | 140M-16.9% | 169M-18.0% | 206M+3.9% | 198M+61.8% | |
| Accrued liabilities | 270M+16.4% | 232M+1.8% | 228M+3.7% | 220M-4.0% | 229M+52.7% | |
| Deferred revenue | 210M-15.3% | 248M+2.7% | 242M-8.5% | 264M+20.3% | 220M+5.7% | |
| Short-term & current debt | 166K+7.1% | 155K-95.1% | 3.17M+135.5% | 1.35M+1233.7% | 101K-99.8% | |
| Current lease liability | 57.7M+6.5% | 54.2M-1.4% | 54.9M+18.0% | 46.5M+39.9% | 33.3M+34.8% | |
| Other current liabilities | 222M+14.5% | 194M-4.5% | 203M-0.7% | 205M+45.7% | 140M+37.0% | |
| Finance lease liability (current) | 3.23M+16.4% | 2.77M+15.7% | 2.40M+2.9% | 2.33M-13.5% | 2.69M-10.7% | |
| 3.92B-2.4% | 4.02B-11.4% | 4.54B-0.9% | 4.58B+3.3% | 4.43B+32.4% | ||
| Long-term debt | 2.14B-4.6% | 2.24B-15.4% | 2.65B-2.2% | 2.71B+1.7% | 2.66B+38.0% | |
| Deferred revenue (non-current) | 45.6M+33.1% | 34.3M+10.9% | 30.9M | — | 20.6M+5.7% | |
| Non-current lease liability | 434M-10.3% | 484M+15.4% | 419M+7.6% | 390M+54.1% | 253M+62.6% | |
| Operating lease liability (total) | 492M-8.6% | 538M+13.5% | 474M+8.7% | 436M+52.4% | 286M+58.8% | |
| Finance lease liability (total) | 27.9M-2.0% | 28.4M-0.4% | 28.6M-6.8% | 30.6M+12.6% | 27.2M-6.3% | |
| Finance lease liability | 24.6M-4.0% | 25.7M-1.8% | 26.2M-7.6% | 28.3M+15.4% | 24.5M-5.8% | |
| Deferred tax liabilities | 95.2M-11.0% | 107M-44.1% | 191M-11.2% | 216M-10.1% | 240M+10.5% | |
| Other non-current liabilities | 138M-29.2% | 195M-12.5% | 223M+27.7% | 175M-28.0% | 243M+18.3% | |
| 3.16B-8.6% | 3.46B-3.8% | 3.60B+20.9% | 2.98B+17.4% | 2.53B+19.9% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 492K-3.7% | 511K-0.4% | 513K+0.8% | 509K+0.8% | 505K+1.4% | |
| Additional paid-in capital | 1.95B-1.0% | 1.97B+3.2% | 1.91B+5.6% | 1.80B+5.0% | 1.72B+5.6% | |
| Retained earnings | 1.39B-23.4% | 1.81B-4.0% | 1.89B+31.7% | 1.43B+46.1% | 981M+56.8% | |
| Treasury stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accumulated other comprehensive income | -172M+45.9% | -317M-61.6% | -196M+25.0% | -262M-59.1% | -165M-18.6% | |
| Non-controlling interest | 5.30M-2.7% | 5.45M+1.0% | 5.39M+12.7% | 4.79M+15.0% | 4.16M+16.7% | |
| Total equity incl. non-controlling | 3.17B-8.6% | 3.47B-3.8% | 3.60B+20.8% | 2.98B+17.4% | 2.54B+19.9% | |
| Total liabilities & equity | 7.14B-5.2% | 7.53B-8.1% | 8.20B+7.8% | 7.60B+8.2% | 7.02B+27.9% | |
| Common shares issued | 49.2M-3.8% | 51.1M-0.4% | 51.3M+0.8% | 50.9M+0.9% | 50.5M+1.4% | |
| Common shares outstanding | 49.2M-3.8% | 51.1M-0.4% | 51.3M+0.8% | 50.9M+0.9% | 50.5M+1.4% | |
| Shares outstanding (cover) | 49.2M-3.7% | 51.1M-0.4% | 51.3M+0.7% | 51.0M+1.0% | 50.5M+1.4% | |
| Cash Flow | as ofDec 27 ’25 | as ofDec 28 ’24 | as ofDec 30 ’23 | as ofDec 31 ’22 | as ofDec 25 ’21 | |
| 738M+0.4% | 735M+7.4% | 684M+10.4% | 620M-18.6% | 761M+39.2% | ||
| Depreciation & amortization | 403M+11.5% | 362M+15.2% | 314M+3.4% | 304M+14.4% | 266M+13.0% | |
| Intangible amortization | 179M+29.3% | 138M+0.8% | 137M-6.2% | 147M+17.4% | 125M+11.6% | |
| Share-based compensation | 71.1M+1.7% | 69.9M-3.0% | 72.0M-2.1% | 73.6M+3.0% | 71.5M+26.9% | |
| Deferred income taxes | -75.4M-12.2% | -67.2M-30.9% | -51.3M-55.1% | -33.1M-63.0% | -20.3M-1382.9% | |
| Change in receivables | -35.7M-65.4% | -21.6M-164.6% | 33.4M-77.8% | 151M+465.4% | 26.6M-68.9% | |
| Change in inventory | 48.8M+390.3% | -16.8M-127.0% | 62.3M-20.7% | 78.5M+212.1% | 25.2M+36.9% | |
| Change in payables | 2.87M+120.1% | -14.3M+30.1% | -20.4M-670.2% | -2.65M-105.9% | 44.9M+5902.8% | |
| -209M+14.6% | -245M+56.5% | -563M+7.4% | -608M+57.7% | -1.44B-139.0% | ||
| Capital expenditure | 219M-5.9% | 233M-26.9% | 319M-1.9% | 325M+41.9% | 229M+37.4% | |
| Free cash flow | 518M+3.4% | 502M+37.3% | 365M+23.9% | 295M-44.6% | 532M+40.0% | |
| Acquisitions | 0.00-100.0% | 5.48M-97.2% | 195M-31.3% | 283M-78.1% | 1.29B+208.9% | |
| Purchases of investments | 20.1M-62.0% | 52.9M-2.5% | 54.2M-65.7% | 158M+247.4% | 45.6M+70.7% | |
| Other investing activities | -3.36M+26.0% | -4.55M-298.3% | 2.29M-75.5% | 9.35M+3640.5% | -264K-124.8% | |
| -537M+2.6% | -551M-544.2% | -85.5M-101.7% | -42.4M-106.3% | 673M+1323.5% | ||
| Long-term debt issued | 1.23B+13.5% | 1.08B+39.3% | 776M-73.7% | 2.95B-57.5% | 6.95B+211.6% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 361M+202.6% | 119M+393.4% | 24.2M-37.5% | 38.7M-5.1% | 40.7M+69.8% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | -14.0M+55.4% | -31.4M-658.6% | -4.14M+46.6% | -7.76M | 0.00+100.0% | |
| FX effect on cash | 18.8M+207.7% | -17.5M-317.2% | 8.04M-68.6% | 25.6M+44.3% | 17.7M+2133.0% | |
| Net change in cash | 10.4M+113.2% | -78.9M-282.4% | 43.3M+948.4% | -5.10M-138.7% | 13.2M+290.5% | |
| Interest paid | 102M-17.6% | 123M-6.5% | 132M+31.1% | 101M+42.4% | 70.8M-2.3% | |
| Income taxes paid | 120M-5.1% | 126M+39.5% | 90.4M+19.1% | 75.9M+0.6% | 75.4M+25.6% | |
| Valuation Ratios | as ofDec 27 ’25 | as ofDec 28 ’24 | as ofDec 30 ’23 | as ofDec 31 ’22 | as ofDec 25 ’21 | |
| Market cap | 10.0B+5.3% | 9.52B-21.5% | 12.1B+9.4% | 11.1B-40.5% | 18.6B+48.8% | |
| P/E | — | 22.5×-12.0% | 25.5×+0.5% | 25.4×-45.9% | 47.0×+13.1% | |
| P/S | 2.5×+6.3% | 2.3×-18.5% | 2.9×-1.9% | 2.9×-46.1% | 5.4×+22.7% | |
| P/B | 2.9×+16.9% | 2.5×-31.4% | 3.7×-13.1% | 4.2×-45.0% | 7.7×+16.3% | |
| P/FCF | 18.4×+8.5% | 17.0×-48.4% | 32.9×-17.0% | 39.6×-3.8% | 41.2×+46.9% | |
| Earnings yield | — | 4.5%+13.7% | 3.9%-0.5% | 3.9%+84.9% | 2.1%-11.6% | |
| FCF yield | 5.4%-7.9% | 5.9%+93.8% | 3.0%+20.5% | 2.5%+4.0% | 2.4%-31.9% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: CRL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CRL filings on SEC EDGAR → Not investment advice.